Signal active
Investment Firm
Overview
Intersect VC is an investment firm that invests at early and later-stage companies. The firm also invests in mid-stage technology companies (Series A-C) in CPG / DTC, marketplaces/platforms, FinTech, and B2B software. They enjoy working with companies that have large potential markets, that can be applied across sectors including media, entertainment, fashion, health/wellness, and sports.
Highlights
2018
Venture Capital
1-10
22
1
2
Early Stage Venture, Seed
Venture Capital
Location
Cambridge, Massachusetts, United States, North America
Contact Information
Social
Profile Resume
Intersect VC, established in 2018 and headquartered in United States, North America., specializes in Early Stage Venture, Seed investments across Information Technology, Software, Social Network, Digital Media, Content, Music, Content Marketing, Telecommunications, Financial Services, Venture Capital. The organization boasts a portfolio of 22 investments, with an average round size of $14.6M and 2 successful exits. Their recent investments include Triller, Carnegie Technologies, Lowercase Capital, round21, Re. The highest investment round they participated in was $17.5B. Among their most notable exits are Triller and Carnegie Technologies. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
22
12
1
2
Investments
22
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Nov 08, 2022 | Juvena Therapeutics | Biotechnology | 41.0M |
Dec 22, 2022 | ROW8 | Film | null |
Jan 01, 2023 | - | - | null |
Jan 01, 2024 | - | - | null |
Exits
2
Funding Timeline
22
0
0
Funding Rounds
22
Intersect VC has raised 22 rounds. Their latest funding was raised on Jan 01, 2024 from a Venture Round - World Armwrestling League round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Nov 08, 2022 | Series A - Juvena Therapeutics | - | 41.0M | - |
Dec 22, 2022 | Venture Round - ROW8 | - | 0 | - |
Jan 01, 2023 | Venture Round - Cent | - | 0 | - |
Jan 01, 2024 | Venture Round - World Armwrestling League | - | 0 | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
Funding Round
Jan 01, 2024
World Armwrestling League raised an undisclosed amount on 2024-01-01 in Venture Round
Funding Round
Jan 01, 2023
Cent raised an undisclosed amount on 2023-01-01 in Venture Round
Funding Round
Dec 22, 2022
ROW8 raised an undisclosed amount on 2022-12-22 in Venture Round
Funding Round
Nov 08, 2022
Juvena Therapeutics raised $41000000 on 2022-11-08 in Series A
Funding Round
Sep 21, 2022
Dame Products raised $7000000 on 2022-09-21 in Series A